Progestogens Modulate the Metabolic but Not the Musculoskeletal Response to Estradiol in a Mouse Model of Adolescent Gender Transition
The FASEB Journal · 15.11.2026 · 40 (21)
DOI: 10.1096/fj.202602013r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 30.10.2026. Verfasst von Sandra Calvo Blanco und 23 weiteren Autor:innen. Beteiligte Einrichtung: Basic and Translational Endocrinology (BaTE) Laboratory, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent Uni…. Hauptthemen laut MEDLINE: Estradiol, Muscle, Skeletal, Progestins. Die Arbeit nennt 95 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek (FWO), UGent|Bijzonder Onderzoeksfonds UGent (BOF), Bijzonder Onderzoeksfonds UGent.
Abstract (Originalsprache)
Gender‐affirming hormone therapy in transgender girls typically consists of gonadotropin‐releasing hormone analog (GnRHa)‐mediated puberty suppression followed by estradiol (E2) treatment. While the skeletal effects of this approach have been investigated, its impact on skeletal muscle and metabolism remains unclear. Moreover, the addition of a progestogen such as natural progesterone (P4) or synthetic medroxyprogesterone acetate (MPA) to the standard E2 regimen has gained popularity due to presumed enhanced feminization, despite limited evidence regarding its effects on musculoskeletal and metabolic tissues. Here, we used a mouse model of adolescent male‐to‐female transition to address these questions. Peripubertal male mice were treated with a GnRHa to suppress endogenous sex hormone production, followed by E2 alone or in combination with P4 or MPA. Puberty suppression reduced the acquisition of bone mass and strength, impaired endurance capacity, decreased lean mass, altered muscle fiber type composition, and increased adiposity. E2 treatment increased bone outcomes to female control levels, and partially normalized endurance capacity, body composition, and metabolic parameters. Addition of a progestogen did not further affect bone or muscle outcomes beyond E2 alone. In contrast, progestogen co‐administration worsened metabolic parameters, resulting in increased adiposity, impaired glucose tolerance, elevated fasting glucose and insulin, and hepatic lipid accumulation. These effects were more pronounced with MPA than with P4. In conclusion, E2 drives musculoskeletal recovery following puberty suppression, whereas progestogens do not provide additional benefits in these tissues. However, they adversely affect metabolic outcomes, highlighting the need for careful evaluation when these compounds are included in gender‐affirming therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Basic and Translational Endocrinology (BaTE) Laboratory, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- VIB Center for Inflammation Research, Ghent University, Ghent, Belgium.
- Unit for Molecular Immunology and Inflammation, Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, Faculty of Medicine, KU Leuven, Leuven, Belgium.
- Translational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Geriatric Department, Ghent University Hospital, Ghent, Belgium.
ORCID-Profile: Vanessa Dubois
Förderung
- Fonds Wetenschappelijk Onderzoek (FWO)
- UGent|Bijzonder Onderzoeksfonds UGent (BOF)
- Bijzonder Onderzoeksfonds UGent
Zitieren
APA
Calvo Blanco, S., Nobus, O., Zhang, B., Tuypens, K., Van Belleghem, K., Liekens, T., Verlinden, L., Stappers, F., Crombez, L., Vercruysse, C., Cherlet, M., Croubels, S., Narinx, N., De Waal, T., Lamon, S., Gracey, E., Elewaut, D., De Spiegeleer, A., Dmitriev, R. I., …, & Dubois, V. (2026). Progestogens Modulate the Metabolic but Not the Musculoskeletal Response to Estradiol in a Mouse Model of Adolescent Gender Transition. The FASEB Journal, 40(21). https://doi.org/10.1096/fj.202602013r
Vancouver
Calvo Blanco S, Nobus O, Zhang B, Tuypens K, Van Belleghem K, Liekens T, et al. Progestogens Modulate the Metabolic but Not the Musculoskeletal Response to Estradiol in a Mouse Model of Adolescent Gender Transition. The FASEB Journal. 2026;40(21). doi:10.1096/fj.202602013r
BibTeX
@article{CalvoBlanco2026,
author = {Calvo Blanco, Sandra and Nobus, Oriana and Zhang, Boya and Tuypens, Karo and Van Belleghem, Karel and Liekens, Toke and Verlinden, Lieve and Stappers, Flore and Crombez, Liesbeth and Vercruysse, Chris and Cherlet, Marc and Croubels, Siska and Narinx, Nick and De Waal, Tom and Lamon, Séverine and Gracey, Eric and Elewaut, Dirk and De Spiegeleer, Anton and Dmitriev, Ruslan I and T'Sjoen, Guy and Cools, Martine and Devisscher, Lindsey and Stegen, Steve and Dubois, Vanessa},
title = {Progestogens Modulate the Metabolic but Not the Musculoskeletal Response to Estradiol in a Mouse Model of Adolescent Gender Transition},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {21},
doi = {10.1096/fj.202602013r}
}
EUVIMED